Cardiopulmonary Rehabilitation for Post-acute COVID-19 Symptoms
Hospital- Versus Home-based Cardiopulmonary Rehabilitation for Post-acute COVID-19 Symptoms
1 other identifier
interventional
88
1 country
1
Brief Summary
The purpose of this RETROSPECTIVE study was to compare the effect of a hospital and home-based cardiopulmonary rehabilitation (CPR) program on exercise endurance and quality of life in post-acute COVID-19 patients. 88 post-acute COVID-19 patients were divided two groups according to receiving hospital (n=45) or home-based CPR (n=43)in our rehabilitation clinic between January and July 2021. Both protocols consisted of aerobic, breathing and flexibility exercises. Hospital-based CPR: three or four days per week for a total of 20 sessions. Home-based CPR: three or four days/a week over a period of six weeks. The results of six meters walk test (6MWT) for exercise endurance as a main outcome measure, and Borg-dyspnea/fatigue, the visual analog scale (VAS) for pain and the Short Form-36 (SF-36) as secondary outcome measures before and after treatment were recorded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 25, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedFirst Submitted
Initial submission to the registry
March 24, 2023
CompletedFirst Posted
Study publicly available on registry
March 28, 2023
CompletedMarch 30, 2023
March 1, 2023
3 months
March 24, 2023
March 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Exercise endurance
Six minutes walk test (All patients walked along a 30-meter-long corridor without obstacles at their normal walking speed, how many meters they walked was noted.)
One day before exercise programme start and one day later exercise programme ends
Secondary Outcomes (4)
Dyspnea
One day before exercise programme start and one day later exercise programme ends
Muscle fatigue
One day before exercise programme start and one day later exercise programme ends
short form 36
One day before exercise programme start and one day later exercise programme ends
Musculoskeletal Pain
One day before exercise programme start and one day later exercise programme ends
Study Arms (2)
Home based cardiopulmonary rehabilitation group
EXPERIMENTALThis was a retrospective study. 43 patients who had home based cardiopulmonary rehabilitation programme between January and July 2023, in our rehabilitation clinic.
Hospital based cardiopulmonary rehabilitation group
EXPERIMENTALThis was a retrospective study. 45 patients who had hospital based cardiopulmonary rehabilitation programme between January and July 2023, in our rehabilitation clinic.
Interventions
Both protocols consisted of aerobic, breathing and flexibility exercises. Hospital-based CPR: three or four days per week for a total of 20 sessions. Home-based CPR: three or four days/a week over a period of six weeks.
Eligibility Criteria
You may qualify if:
- being 18 years or older
- having COVID-19 treatment (home quarantine/hospital/intensive care unit) according to a positive polymerase chain reaction (PCR) test in a nasopharyngeal + oropharyngeal swab or chest computed tomography (CT)
- participating in a home-based exercise program (for 6 weeks) or hospital-based CPR (for 12-20 sessions) due to post-acute COVID-19 symptoms (fatigue, myalgia, dyspnea).
You may not qualify if:
- Patients who had both a negative PCR test and chest CT
- Patients who had not completed the six minute walk test (6MWT), Borg scales, Short Form-36 and Visual analog scale-pain.
- Acute COVID-19 patients (patients whose symptoms had started less than one month previous)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eskişehir Osmangazi University
Eskişehir, Odunpazarı, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Fulya Bakılan, Assoc. Prof.
Eskişehir Osmangazi University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 24, 2023
First Posted
March 28, 2023
Study Start
April 16, 2021
Primary Completion
July 25, 2021
Study Completion
July 31, 2021
Last Updated
March 30, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share